Fulvestrant 250mg Injection

Product Description

Fulvestrant 250mg Injection is a medication used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced breast cancer in postmenopausal women. This works by binding to estrogen receptors (ERs) in breast cancer cells, resulting in the degradation of the ERs and preventing them from activating gene transcription. It belongs to a class of drugs known as selective estrogen receptor degraders (SERDs). Fulvestrant 250mg Injection is effective in slowing down the progression of HR+ metastatic breast cancer in postmenopausal women, both as a first-line treatment and in patients who have progressed after prior endocrine therapy.

Specification